Citius Pharmaceuticals Inc (CTXR)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $14.69M
Last updated: Nov 17, 2026 at 11:00 AM ET
Citius Pharmaceuticals Inc (CTXR) Stock Forecast
Analysts expect Citius Pharmaceuticals (CTXR) to earn -$1.44 per share in the fiscal year ending Sep 30, 2027, on revenue of $20.52M. Over the last 30 days, 0 estimates for the fiscal year ending Sep 30, 2027 were revised up and 1 down. For the quarter ending Dec 31, 2026, the EPS consensus is -$0.38.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
- Fiscal year ending Sep 30, 2027
- -$1.44
- EPS consensus, revenue $20.52M
- Next report
- Dec 21, 2026
- Estimated
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Sep 30, 2027 | -$1.44 | -$1.44 to -$1.44 | 1 | $20.52M | $20.52M to $20.52M | 1 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.38 | -$0.38 to -$0.38 | 1 | $4.40M | $4.40M to $4.40M | 1 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 0 upward and 1 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Sep 30, 2027 | 0 | 1 |
| Quarter ending Dec 31, 2026 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Sep 30, 2027 has turned from a profit of $0.99 to a loss.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Sep 30, 2027 | -$1.44 | -$0.81 | -$0.81 | -$0.81 | $0.99 | N/A |
Frequently Asked Questions About CTXR
What is the CTXR stock forecast?
Consensus analyst estimates put Citius Pharmaceuticals's EPS at -$1.44 for the fiscal year ending Sep 30, 2027, on revenue of $20.52M.
What EPS do analysts expect from CTXR next year?
For the fiscal year ending Sep 30, 2027, the consensus EPS estimate is -$1.44, with estimates from -$1.44 to -$1.44 from 1 analyst.
What revenue do analysts expect from Citius Pharmaceuticals next year?
For the fiscal year ending Sep 30, 2027, the consensus revenue estimate is $20.52M, with estimates from $20.52M to $20.52M.
How many analysts cover CTXR?
1 analyst estimates EPS for Citius Pharmaceuticals for the fiscal year ending Sep 30, 2027.
CTXR pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors